Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II
1
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, and Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN 47907, USA
2
Septerna Inc., San Francisco, CA 94080, USA
3
Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria
*
Authors to whom correspondence should be addressed.
Molecules 2022, 27(10), 3140; https://doi.org/10.3390/molecules27103140
Received: 9 May 2022
/
Accepted: 12 May 2022
/
Published: 13 May 2022
(This article belongs to the Special Issue Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II)
Note: In lieu of an abstract, this is an excerpt from the first page.
A few neurotransmitter systems have fascinated the research community, as muchas the opioid system (i.e., opioid ligands and their receptors) [...] View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Van Rijn, R.M.; Spetea, M. Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II. Molecules 2022, 27, 3140. https://doi.org/10.3390/molecules27103140
AMA Style
Van Rijn RM, Spetea M. Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II. Molecules. 2022; 27(10):3140. https://doi.org/10.3390/molecules27103140
Chicago/Turabian StyleVan Rijn, Richard M., and Mariana Spetea. 2022. "Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II" Molecules 27, no. 10: 3140. https://doi.org/10.3390/molecules27103140
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
